Gurgaon Samachar

Urinalysis Market: Meticulous Research® Reveals Why this Market is Growing at a CAGR of 4.5% to reach $2.19 Billion by 2027

 Breaking News
  • No posts were found

Urinalysis Market: Meticulous Research® Reveals Why this Market is Growing at a CAGR of 4.5% to reach $2.19 Billion by 2027

September 02
19:06 2021
Urinalysis Market: Meticulous Research® Reveals Why this Market is Growing at a CAGR of 4.5% to reach $2.19 Billion by 2027
The urinalysis market is expected to grow at a CAGR of 4.5% from 2020 to 2027 to reach $2.19 billion by 2027.
Urinalysis Market by Product (Pregnancy and Fertility Test, Dipstick, Reagent, Automatic, Semi-automatic, and POC Analyzer), Application (Pregnancy, Diabetes, Kidney Disease, UTI), End-user (Hospitals and Clinics, Laboratory, Home Care) – Forecast to 2027

Urinalysis is one of the important procedures in the diagnosis of renal and urologic diseases. A complete urinalysis includes physical, chemical, and microscopic examinations. The physical and chemical examinations include analyzing the appearance or color of urine samples; its specific gravity & pH; and the presence of compounds such as nitrites, urobilinogen, bilirubin, glucose, ketones, protein, and blood. Further, the development of advanced urinalysis products has brought increased automation, ease of use, and more accurate analysis for various screening of diseases. In addition to automated systems, integrated urine analyzers help to analyze urine chemistry and its sediments in one go. Also, miniaturization of devices helps in diagnosing urine diseases at the point of care settings.

Meticulous Research®, in its latest publication on the urinalysis market, states that this market is expected to grow at a CAGR of 4.5% from 2019 to 2027 to reach $2.19 billion by 2027. The growth of the urinalysis market is mainly attributed to factors such as the rising global prevalence of kidney diseases and urinary tract infections, growing awareness regarding regular health checkups amongst the geriatric population, and introduction of technologically advanced diagnostic products. In addition, the adoption of integrated systems for urinalysis will further provide significant growth opportunities for this market.

Download Free Sample Report Copy Here :

Scope of the Report:

Urinalysis Market, by Product

  • Consumables
    • Pregnancy & Fertility Tests
    • Dipstick
    • Other Consumables
  • Instruments
    • Automated Urine Analyzers
    • Biochemical Urine Analyzers
    • Sediment Urine Analyzers
    • Semi-Automated Urine Analyzers
    • Integrated Urine Analyzers
    • Point-of-care Analyzers

Urinalysis Market, by Application

  • Disease Screening
    • Urinary Tract Infections
    • Kidney Diseases
    • Diabetes
    • Other Diseases
  • Pregnancy & Fertility Testing

Urinalysis Market, by End User

  • Diagnostic Laboratories
  • Hospitals & Clinics
  • Home Care Settings
  • Research Laboratories & Institutes

Urinalysis Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • Japan
    • China
    • India
    • Rest of APAC (RoAPAC)
  • Latin America
  • Middle East & Africa

Speak to our Analysts to Understand the Impact of COVID-19 on Your Business :

To provide efficient analysis, Meticulous Research® has segmented this market by product [consumables (pregnancy & fertility tests, dipstick, other consumables), instrument (biochemical urine analyzers, sediment urine analyzers, semi-automated urine analyzers, integrated urine analyzers)], application [disease screening (urinary tract infections, kidney diseases, diabetes, other diseases), and pregnancy & fertility testing], end user [hospitals & clinics, diagnostic laboratories, home care settings, research laboratories & institutes], and geography [North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa].

Wherein, geographically, North America is estimated to command the largest share of the urinalysis market in 2020, followed by Europe and Asia-Pacific. However, China is expected to grow at the fastest CAGR during the forecast period. The rise in the aging population with increasing bladder cancer and diabetes cases, increasing investments in healthcare infrastructure facilities, growing regulatory support for marketing of IVDs in the country, and the presence of local urinalysis product manufacturers based in China are the major driving factors.

Based on product, the consumables segment is expected to grow at the highest CAGR during the forecast period. Moreover, in the instruments market, the point-of-care analyzers segment is expected to grow at the highest CAGR. The growth of the segment is attributed to features, such as their compact size, portability, and ease of accessibility, which has led to their increased adoption for quicker analysis as compared to centralized lab analyzers.

Based on application, the disease screening segment is estimated to hold the largest share of the overall urinalysis market in 2020. Moreover, the UTI segment under disease screening is expected to grow at the highest CAGR during the forecast period. The major reason for the growth of this segment is the increasing prevalence of urinary tract infections and hospital-acquired urinary tract infections.

Based on end user, the home care settings segment is expected to grow at the highest CAGR during the forecast period owing to recent innovations in point-of-care devices and the availability of home-based kits to analyze urine at home care settings.

To gain more insights into the market with a detailed table of content and figures, click here :

Key Players

The report provides competitive intelligence in terms of financials, growth strategies, product portfolios, and geographical presence on some of the key players operating in this market, including Bio-Rad Laboratories, Inc. (U.S.), Beckman Coulter, Inc. (U.S.), F. Hoffmann-La Roche (Switzerland), Siemens Healthineers (Germany), Sysmex Corporation (Japan), ARKRAY, Inc (Japan), ACON Laboratories, Inc. (U.S.), Cardinal Health, Inc. (U.S.), URIT Medical Electronic Group Co., Ltd. (China), and 77 Elektronika Kft. (Hungary).

Amidst this crisis, Meticulous Research® is continuously assessing the impact of COVID-19 pandemic on various sub-markets and enables global organizations to strategize for the post-COVID-19 world and sustain their growth. Let us know if you would like to assess the impact of COVID-19 on any industry here-

About Meticulous Research®

Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.

Media Contact
Company Name: Meticulous Market Research Pvt Ltd
Contact Person: Khushal Bombe
Email: Send Email
Phone: +1 646-781-8004
Address:1267 Willis St, Ste 200 Redding, California, 96001, U.S.
Country: United States

Warning: count(): Parameter must be an array or an object that implements Countable in /home/haridwartoday/ on line 5